- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Cholesterol esters.
Displaying page 1 of 1.
EudraCT Number: 2021-001080-24 | Sponsor Protocol Number: NL76906.068.21 | Start Date*: 2021-04-08 |
Sponsor Name:Maastricht University | ||
Full Title: The effect of plant stanol ester consumption on the vaccination response to a COVID-19 vaccine | ||
Medical condition: COVID-19 vaccination respons of people with BMI 27-35 kg/m2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-004750-24 | Sponsor Protocol Number: 2013003 | Start Date*: 2014-03-17 | |||||||||||
Sponsor Name:Rode Kruis Ziekenhuis | |||||||||||||
Full Title: Omega-3 fatty acids in bariatric gastric bypass surgery: effects on liver volume, immune response and erythrocyte function | |||||||||||||
Medical condition: Patients qualified for bariatric surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001921-86 | Sponsor Protocol Number: S185.4.001 | Start Date*: 2007-07-19 | |||||||||||
Sponsor Name:Solvay Pharmaceuticals GmbH | |||||||||||||
Full Title: A double-blind, placebo-controlled, parallel-group, multi-center study to investigate the effect of Omacor (n-3 PUFA) on lipid parameters in HIV infected patients treated with HAART | |||||||||||||
Medical condition: HAART-induced hypertriglyeridemia in HIV infected subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018369-48 | Sponsor Protocol Number: CASTIP3 | Start Date*: 2011-03-10 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Der Einfluss von Adalimumab auf kardiovaskuläre und metabolische Risikofaktoren in der Therapie von Patienten mit mittelschwerer bis schwerer Psoriasis vulgaris im Vergleich zu einer Standardtherap... | |||||||||||||
Medical condition: Psoriasis vulgaris | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
